Otezla (apremilast) is a prescription medication approved by the FDA to treat active psoriatic arthritis and moderate to severe plaque psoriasis in adults. It works by decreasing inflammation and pain.

Key Points
- Effectiveness: People taking Otezla were five times more likely to have less severe disease after four Show Full Answer

Otezla (apremilast) is a prescription medication approved by the FDA to treat active psoriatic arthritis and moderate to severe plaque psoriasis in adults. It works by decreasing inflammation and pain.

Key Points:
- Effectiveness: People taking Otezla were five times more likely to have less severe disease after four months compared to those on a placebo.
- Improvements: Users experienced smaller affected skin areas, less scalp involvement, and reduced itching.
- Side Effects: Common side effects include diarrhea, nausea, upper respiratory infections, and headaches. More serious side effects can include weight loss, vomiting, and depression.

For more detailed experiences, you might want to visit the MyPsoriasisTeam website.

 This AI-generated response comes from MyPsoriasisTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Otezla Now Approved for All Severity Levels of Psoriasis | MyPsoriasisTeam

Otezla (Apremilast) for Psoriasis | MyPsoriasisTeam